Latest Product News
Latest Tools for COVID-19 Omicron Variant Research
AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2.
AffiDX® SARS-CoV-2 Antigen Lateral Flow Test and Detection of Omicron
Avacta Group plc, a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics, provides an update on the performance of the AffiDX® SARS-CoV-2 antigen lateral flow test (LFT) with the Omicron variant.
Rapid Rack Readers Help Labs Lower Cost of COVID-19 PCR Testing
Ziath reports how its super-fast 2D barcode rack readers are assisting COVID-19 testing lab – SummerBio LLC to offer rapid, low-cost, high-volume testing solutions for educational organizations, employers and laboratories.
Sino Biological Establishes New Location in Houston, Texas
Sino Biological, Inc. is pleased to announce its physical geographic expansion, adding a new location in Houston, Texas.
Sino Biological Deposits Recombinant Omicron Proteins and Antibodies to BEI Resources
Sino Biological, Inc. has recently deposited reagents for the Omicron variant, including recombinant proteins to Spike and Nucleocapsid, and antibody products to BEI Resources.
Evotec receives € 7.5 m grant for development of COVID-19 therapeutic
Evotec SE has announced that the Company has been selected by the German Federal Ministry of Education and Research to receive a grant for the development of a potential first-in-class immunomodulatory therapy against COVID 19.
Managing and Maintaining Sterile Manufacturing with Environmental Monitoring LIMS
Following the recent success of the webinar Managing and Maintaining Sterile Manufacturing with Environmental Monitoring, Autoscribe Informatics has made the recording available for Quality Management personnel and other interested parties.
Eppendorf Research Plus is the First Pipette To Receive My Green Lab ACT Label
The Eppendorf Research® plus single-channel pipette line-up with variable volume has been certified with an “ACT®” Environmental Impact Factor Label by the “My Green Lab®” non-profit organization.
MAPS and Wesana Health Resume Final Negotiations
Analysis indicates viability of research pathway for MDMA-assisted therapy to treat symptoms associated with traumatic brain injury.
Ziath Supports Mental Health Charity for Young People
Cambridge, UK, based sample management experts - Ziath Ltd are putting a bit of Christmas cheer in the hearts and minds of young people in London suffering from mental health issues.